Health Supervision for Children With Neurofibromatosis Type 1

Author:

Miller David T.1,Freedenberg Debra2,Schorry Elizabeth3,Ullrich Nicole J.4,Viskochil David5,Korf Bruce R.6,Chen Emily,Trotter Tracy L.,Berry Susan A.,Burke Leah W.,Geleske Timothy A.,Hamid Rizwan,Hopkin Robert J.,Introne Wendy J.,Lyons Michael J.,Scheuerle Angela E.,Stoler Joan M., ,

Affiliation:

1. Division of Genetics and Genomics and

2. Texas Department of State Health Services, Austin, Texas;

3. Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio;

4. Department of Neurology, Harvard Medical School, Harvard University and Boston Children’s Hospital, Boston, Massachusetts;

5. Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah; and

6. Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama

Abstract

Neurofibromatosis type 1 (NF1) is a multisystem disorder that primarily involves the skin and peripheral nervous system. Its population prevalence is approximately 1 in 3000. The condition is usually recognized in early childhood, when pigmentary manifestations emerge. Although NF1 is associated with marked clinical variability, most children affected follow patterns of growth and development within the normal range. Some features of NF1 can be present at birth, but most manifestations emerge with age, necessitating periodic monitoring to address ongoing health and developmental needs and minimize the risk of serious medical complications. In this report, we provide a review of the clinical criteria needed to establish a diagnosis, the inheritance pattern of NF1, its major clinical and developmental manifestations, and guidelines for monitoring and providing intervention to maximize the health and quality of life of a child affected.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Reference75 articles.

1. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.;Evans;Am J Med Genet A,2010

2. Health supervision for children with neurofibromatosis.;Hersh;Pediatrics,2008

3. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.;Arch Neurol,1988

4. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987.;Neurofibromatosis,1988

5. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.;DeBella;Pediatrics,2000

Cited by 116 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3